Stay updated on Pembrolizumab in HR-Competent & Deficient Tumors Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in HR-Competent & Deficient Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in HR-Competent & Deficient Tumors Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page now indicates that the study is completed and no longer looking for participants. Enrollment has closed and no new participants are being sought.
    Difference
    0.5%
    Check dated 2026-06-12T13:23:16.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.5.4 to v3.5.5, indicating a new version of the page or its template. This is a metadata update and does not reflect substantive changes to the study data or content.
    Difference
    0.1%
    Check dated 2026-06-05T10:08:04.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.3 to v3.5.4, signalling a platform update. No study data or page content was changed.
    Difference
    0.1%
    Check dated 2026-05-15T05:29:18.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.3, signaling an updated site version. This update does not alter the study’s content or outcomes, and is a backend/version change rather than a content modification.
    Difference
    0.1%
    Check dated 2026-04-30T18:47:26.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Revision: v3.5.2 was added and Revision: v3.5.0 was removed from the page.
    Difference
    0.1%
    Check dated 2026-04-16T10:55:22.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    Revision text updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-18T15:45:26.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in HR-Competent & Deficient Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in HR-Competent & Deficient Tumors Clinical Trial page.